KLRA — KAILERA THERAPEUTICS INC
As of Q2 2026, 28 SEC-registered investment managers reported holding KLRA (KAILERA THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $593.46M across 30.47M shares. Ownership is concentrated: the five largest holders account for 79.3% of reported value and the top ten for 94.3%.
Compared with the prior quarter, 28 opened new positions. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
KLRA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| CPP Investments history | Q2 2026 | 7.30M | $160.92M | 0.09% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 3.97M | $87.48M | 0.00% | New |
| BlackRock Inc history | Q2 2026 | 3.93M | $86.55M | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 3.24M | $71.39M | 0.01% | New |
| Wellington Management Group history | Q2 2026 | 2.92M | $64.31M | 0.01% | New |
| Geode Capital Management history | Q2 2026 | 1.13M | $24.97M | 0.00% | New |
| Farallon Capital Management history | Q2 2026 | 1.10M | $24.23M | 0.11% | New |
| UBS Group AG history | Q2 2026 | 972.68K | $21.43M | 0.00% | New |
| Goldman Sachs Group history | Q2 2026 | 421.03K | $9.28M | 0.00% | New |
| Franklin Resources history | Q2 2026 | 400.02K | $8.81M | 0.00% | New |
| Charles Schwab Investment Management history | Q2 2026 | 362.91K | $7.99M | 0.00% | New |
| Northern Trust Corp history | Q2 2026 | 354.43K | $7.81M | 0.00% | New |
| Balyasny Asset Management history | Q2 2026 | 154.84K | $3.41M | 0.00% | New |
| Manulife Financial history | Q2 2026 | 149.82K | $3.30M | 0.00% | New |
| BNY Mellon history | Q2 2026 | 138.40K | $3.05M | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 57.79K | $1.27M | 0.00% | New |
| Bank of America Corp history | Q2 2026 | 56.51K | $1.24M | 0.00% | New |
| Lazard Asset Management history | Q2 2026 | 48.39K | $1.07M | 0.00% | New |
| Deutsche Bank AG history | Q2 2026 | 45.65K | $1.01M | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 43.12K | $949.93K | 0.00% | New |
New Positions (Q2 2026)
- CPP Investments 7.30M sh · $160.92M
- Fidelity Management & Research (FMR) 3.97M sh · $87.48M
- BlackRock Inc 3.93M sh · $86.55M
- Citadel Advisors 3.24M sh · $71.39M
- Wellington Management Group 2.92M sh · $64.31M
- Geode Capital Management 1.13M sh · $24.97M
- Farallon Capital Management 1.10M sh · $24.23M
- UBS Group AG 972.68K sh · $21.43M
- Goldman Sachs Group 421.03K sh · $9.28M
- Franklin Resources 400.02K sh · $8.81M
- Charles Schwab Investment Management 362.91K sh · $7.99M
- Northern Trust Corp 354.43K sh · $7.81M
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q4 2023 | Q2 2026 |
|---|---|---|---|---|---|---|
| CPP Investments | — | — | — | — | — | 7.30M |
| Fidelity Management & Research (FMR) | — | — | — | — | — | 3.97M |
| BlackRock Inc | — | — | — | — | — | 3.93M |
| Citadel Advisors | — | — | — | — | — | 3.24M |
| Wellington Management Group | — | — | — | — | — | 2.92M |
| Geode Capital Management | — | — | — | — | — | 1.13M |
| Farallon Capital Management | — | — | — | — | — | 1.10M |
| UBS Group AG | — | — | — | — | — | 972.68K |
| Goldman Sachs Group | — | — | — | — | — | 421.03K |
| Franklin Resources | — | — | — | — | — | 400.02K |
| Charles Schwab Investment Management | — | — | — | — | — | 362.91K |
| Northern Trust Corp | — | — | — | — | — | 354.43K |
| Balyasny Asset Management | — | — | — | — | — | 154.84K |
| Manulife Financial | — | — | — | — | — | 149.82K |
| BNY Mellon | — | — | — | — | — | 138.40K |
| Morgan Stanley | — | — | — | — | — | 57.79K |
| Bank of America Corp | — | — | — | — | — | 56.51K |
| Lazard Asset Management | — | — | — | — | — | 48.39K |
| Deutsche Bank AG | — | — | — | — | — | 45.65K |
| Wells Fargo & Co | — | — | — | — | — | 43.12K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details